| (+)-catechin | decreases expression | ISO | RGD:732023 | 6480464 | Catechin results in decreased expression of MAP2K1 mRNA; more ... | CTD | PMID:15465739 |
| (+)-catechin | multiple interactions | ISO | RGD:732023 | 6480464 | Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased phosphorylation of MAP2K1 protein] | CTD | PMID:21882252 |
| (+)-catechin | increases expression | ISO | RGD:732023 | 6480464 | Catechin results in increased expression of MAP2K1 mRNA | CTD | PMID:15465739 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:1550208 | 6480464 | Ethinyl Estradiol affects the expression of MAP2K1 mRNA | CTD | PMID:17555576 |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of MAP2K1 mRNA | CTD | PMID:17108234 |
| 17beta-estradiol | increases activity | ISO | RGD:732023 | 6480464 | Estradiol results in increased activity of MAP2K1 protein | CTD | PMID:15615701 |
| 17beta-estradiol | increases expression | ISO | RGD:732023 | 6480464 | Estradiol results in increased expression of MAP2K1 mRNA | CTD | PMID:12154049 |
| 17beta-estradiol | affects expression | ISO | RGD:732023 | 6480464 | Estradiol affects the expression of MAP2K1 mRNA | CTD | PMID:22574217 |
| 17beta-estradiol | affects expression | ISO | RGD:1550208 | 6480464 | Estradiol affects the expression of MAP2K1 mRNA | CTD | PMID:15598610 |
| 17beta-estradiol | increases expression | ISO | RGD:1550208 | 6480464 | Estradiol results in increased expression of MAP2K1 mRNA | CTD | PMID:14664709 |
| 17beta-hydroxy-5alpha-androstan-3-one | multiple interactions | ISO | RGD:732023 | 6480464 | Dihydrotestosterone results in increased phosphorylation of and results in increased activity of MAP2K1 protein; more ... | CTD | PMID:15466214 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases activity | ISO | RGD:732023 | 6480464 | Tetrachlorodibenzodioxin results in increased activity of MAP2K1 protein | CTD | PMID:15313166 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1550208 | 6480464 | MAP2K1 protein promotes the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein modified form binds to ARNT protein modified form]]; more ... | CTD | PMID:20450880 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1550208 | 6480464 | Tetrachlorodibenzodioxin affects the expression of MAP2K1 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1550208 | 6480464 | MAP2K1 protein promotes the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein] | CTD | PMID:12213569 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1550208 | 6480464 | MAP2K1 protein promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG protein] | CTD | PMID:12758056 |
| 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of MAP2K1 mRNA | CTD | PMID:21346803 |
| 2-arachidonoylglycerol | multiple interactions | EXP | | 6480464 | 2-arachidonylglycerol results in increased phosphorylation of and results in increased activity of MAP2K1 protein; more ... | CTD | PMID:12657697 |
| 2-methylcholine | affects expression | ISO | RGD:732023 | 6480464 | beta-methylcholine affects the expression of MAP2K1 mRNA | CTD | PMID:21179406 |
| 3',5'-cyclic GMP | multiple interactions | ISO | RGD:732023 | 6480464 | Cyclic GMP affects the reaction [NPPA protein alternative form results in decreased phosphorylation of and results in decreased activity of MAP2K1 protein] | CTD | PMID:18225537 |
| 3',5'-cyclic GMP | decreases phosphorylation | ISO | RGD:732023 | 6480464 | Cyclic GMP results in decreased phosphorylation of MAP2K1 protein | CTD | PMID:18225537 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [FSHB protein co-treated with 1-Methyl-3-isobutylxanthine] inhibits the reaction [Testosterone promotes the reaction [RAF1 results in increased phosphorylation of MAP2K1 protein]] | CTD | PMID:21177760 |
| 3H-1,2-dithiole-3-thione | decreases expression | EXP | | 6480464 | 1,2-dithiol-3-thione results in decreased expression of MAP2K1 mRNA | CTD | PMID:19162173 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | multiple interactions | ISO | RGD:732023 | 6480464 | [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased phosphorylation of MAP2K1 protein; more ... | CTD | PMID:21882252 |
| 5-(2-methylpiperazine-1-sulfonyl)isoquinoline | decreases phosphorylation | ISO | RGD:1550208 | 6480464 | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine results in decreased phosphorylation of MAP2K1 protein | CTD | PMID:14654170 |
| 5-(2-methylpiperazine-1-sulfonyl)isoquinoline | multiple interactions | ISO | RGD:1550208 | 6480464 | [1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine co-treated with TNF protein] results in decreased phosphorylation of MAP2K1 protein | CTD | PMID:14654170 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:732023 | 6480464 | decitabine results in increased expression of MAP2K1 mRNA | CTD | PMID:17785578 |
| 5-fluorouracil | multiple interactions | ISO | RGD:732023 | 6480464 | [U 0126 results in decreased activity of MAP2K1 protein] results in increased susceptibility to [Fluorouracil co-treated with Cisplatin]; more ... | CTD | PMID:21444628 |
| acetylsalicylic acid | increases expression | ISO | RGD:732023 | 6480464 | Aspirin results in increased expression of MAP2K1 mRNA | CTD | PMID:20457246 |
| afimoxifene | increases expression | ISO | RGD:732023 | 6480464 | 4-hydroxytamoxifen results in increased expression of MAP2K1 mRNA | CTD | PMID:12154049 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:732023 | 6480464 | [Tretinoin co-treated with Paclitaxel] results in decreased expression of MAP2K1 protein | CTD | PMID:18098270 |
| all-trans-retinoic acid | increases phosphorylation | ISO | RGD:732023 | 6480464 | Tretinoin results in increased phosphorylation of MAP2K1 protein | CTD | PMID:19038232 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:732023 | 6480464 | Tretinoin results in decreased expression of MAP2K1 protein | CTD | PMID:18098270 |
| all-trans-retinol | multiple interactions | EXP | | 6480464 | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Vitamin A results in increased phosphorylation of MAP2K1 protein]; more ... | CTD | PMID:16510265 |
| all-trans-retinol | increases phosphorylation | EXP | | 6480464 | Vitamin A results in increased phosphorylation of MAP2K1 protein | CTD | PMID:16510265 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of MAP2K1 mRNA | CTD | PMID:16483693 |
| ammonium chloride | increases expression | EXP | | 6480464 | Ammonium Chloride results in increased expression of MAP2K1 mRNA | CTD | PMID:12420312 |
| anandamide | multiple interactions | EXP | | 6480464 | PD 98059 inhibits the reaction [anandamide results in increased phosphorylation of and results in increased activity of MAP2K1 protein]; more ... | CTD | PMID:12657697 |
| anthranilic acid | decreases activity | ISO | RGD:732023 | 6480464 | anthranilic acid results in decreased activity of MAP2K1 protein | CTD | PMID:18393446 |
| arachidonic acid | multiple interactions | ISO | RGD:732023 | 6480464 | FOS protein affects the reaction [MAP2K1 protein inhibits the reaction [Arachidonic Acid results in increased expression of FASLG protein]]; more ... | CTD | PMID:19720122 |
| arsenic acid | increases activity | ISO | RGD:732023 | 6480464 | arsenic acid results in increased activity of MAP2K1 protein | CTD | PMID:14674888 |
| arsenite(3-) | increases activity | ISO | RGD:732023 | 6480464 | arsenite results in increased activity of MAP2K1 protein | CTD | PMID:14674888 |
| ATP | affects binding | ISO | RGD:1550208 | 6480464 | Adenosine Triphosphate binds to MAP2K1 protein | CTD | PMID:17693661 |
| azathioprine | decreases phosphorylation | ISO | RGD:732023 | 6480464 | Azathioprine results in decreased phosphorylation of MAP2K1 protein | CTD | PMID:12697733 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1550208 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of MAP2K1 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:732023 | 6480464 | Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased phosphorylation of MAP2K1 protein] | CTD | PMID:21882252 |
| benzo[a]pyrene | increases expression | ISO | RGD:1550208 | 6480464 | Benzo(a)pyrene results in increased expression of MAP2K1 mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1550208 | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of MAP2K1 mRNA] | CTD | PMID:22228805 |
| beryllium difluoride | increases phosphorylation | ISO | RGD:1550208 | 6480464 | beryllium fluoride results in increased phosphorylation of MAP2K1 protein | CTD | PMID:11867686 |
| bicalutamide | multiple interactions | ISO | RGD:732023 | 6480464 | bicalutamide inhibits the reaction [Dihydrotestosterone results in increased phosphorylation of and results in increased activity of MAP2K1 protein]; more ... | CTD | PMID:15466214 |
| bis(2-chloroethyl) sulfide | increases expression | ISO | RGD:1550208 | 6480464 | Mustard Gas results in increased expression of MAP2K1 mRNA | CTD | PMID:18955075 |
| cadmium atom | increases phosphorylation | ISO | RGD:732023 | 6480464 | Cadmium results in increased phosphorylation of MAP2K1 protein | CTD | PMID:14499349 |
| cadmium atom | multiple interactions | ISO | RGD:732023 | 6480464 | GPR30 mutant form inhibits the reaction [Cadmium results in increased activity of MAP2K1 protein] | CTD | PMID:20153348 |
| cadmium atom | increases activity | ISO | RGD:732023 | 6480464 | Cadmium results in increased activity of MAP2K1 protein | CTD | PMID:20153348 |
| cadmium dichloride | multiple interactions | ISO | RGD:1550208 | 6480464 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K1 protein]; more ... | CTD | PMID:11858940 |
| cadmium dichloride | increases phosphorylation | ISO | RGD:732023 | 6480464 | Cadmium Chloride results in increased phosphorylation of MAP2K1 protein | CTD | PMID:18703135 |
| cadmium dichloride | increases phosphorylation | EXP | | 6480464 | Cadmium Chloride results in increased phosphorylation of MAP2K1 protein | CTD | PMID:18703135 |
| cadmium dichloride | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K1 protein] | CTD | PMID:18703135 |
| cadmium dichloride | multiple interactions | ISO | RGD:732023 | 6480464 | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K1 protein] | CTD | PMID:18703135 |
| cadmium dichloride | increases phosphorylation | ISO | RGD:1550208 | 6480464 | Cadmium Chloride results in increased phosphorylation of MAP2K1 protein | CTD | PMID:11858940 |
| calcium atom | multiple interactions | EXP | | 6480464 | [Sumatriptan results in increased abundance of Calcium] inhibits the reaction [MAP2K1 protein results in increased expression of CALCA mRNA]; more ... | CTD | PMID:12574409 |
| calcium(0) | multiple interactions | EXP | | 6480464 | [Sumatriptan results in increased abundance of Calcium] inhibits the reaction [MAP2K1 protein results in increased expression of CALCA mRNA]; more ... | CTD | PMID:12574409 |
| capsaicin | increases expression | ISO | RGD:732023 | 6480464 | Capsaicin results in increased expression of MAP2K1 mRNA | CTD | PMID:19502594 |
| celecoxib | decreases phosphorylation | ISO | RGD:732023 | 6480464 | celecoxib results in decreased phosphorylation of MAP2K1 protein | CTD | PMID:16123214 |
| chlorpyrifos | decreases expression | EXP | | 6480464 | Chlorpyrifos results in decreased expression of MAP2K1 mRNA | CTD | PMID:18668222 |
| cisplatin | increases phosphorylation | ISO | RGD:732023 | 6480464 | Cisplatin results in increased phosphorylation of MAP2K1 protein | CTD | PMID:21444628 |
| cisplatin | multiple interactions | ISO | RGD:1550208 | 6480464 | MAP2K1 protein promotes the reaction [Cisplatin results in increased activity of CASP3 protein]; more ... | CTD | PMID:20547441 |
| cisplatin | multiple interactions | ISO | RGD:732023 | 6480464 | MAP2K1 protein results in decreased susceptibility to [Cisplatin co-treated with Fluorouracil]; more ... | CTD | PMID:21444628 |
| clozapine | decreases expression | EXP | | 6480464 | Clozapine results in decreased expression of MAP2K1 mRNA | CTD | PMID:15860345 |
| cobalt dichloride | increases expression | ISO | RGD:732023 | 6480464 | cobaltous chloride results in increased expression of MAP2K1 mRNA | CTD | PMID:19376846 |
| cobalt dichloride | multiple interactions | ISO | RGD:732023 | 6480464 | [PD 98059 results in decreased activity of MAP2K1 protein] which results in decreased susceptibility to cobaltous chloride; more ... | CTD | PMID:14536030 |
| cocaine | decreases expression | ISO | RGD:732023 | 6480464 | Cocaine results in decreased expression of MAP2K1 mRNA | CTD | PMID:12629581 |
| cocaine | multiple interactions | ISO | RGD:1550208 | 6480464 | CDK5R1 protein inhibits the reaction [Cocaine results in increased phosphorylation of MAP2K1 protein] | CTD | PMID:15665076 |
| cocaine | increases phosphorylation | ISO | RGD:1550208 | 6480464 | Cocaine results in increased phosphorylation of MAP2K1 protein | CTD | PMID:15665076 |
| copper(2+) sulfate | increases expression | ISO | RGD:732023 | 6480464 | Copper Sulfate results in increased expression of MAP2K1 mRNA | CTD | PMID:19549813 |
| copper(2+) sulfate | multiple interactions | ISO | RGD:732023 | 6480464 | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [Copper Sulfate results in increased phosphorylation of MAP2K1 protein]; more ... | CTD | PMID:10564177 |
| crocidolite asbestos | multiple interactions | ISO | RGD:1550208 | 6480464 | MAP2K1 protein affects the reaction [Asbestos, Crocidolite results in increased phosphorylation of MAPK1 protein]; more ... | CTD | PMID:18192500 |
| crocidolite asbestos | increases phosphorylation | ISO | RGD:732023 | 6480464 | Asbestos, Crocidolite results in increased phosphorylation of MAP2K1 protein | CTD | PMID:18314537 |
| cumene | multiple interactions | ISO | RGD:1550208 | 6480464 | [cumene co-treated with KRAS gene mutant form] results in increased expression of MAP2K1 mRNA; more ... | CTD | PMID:18648096 |
| curcumin | multiple interactions | ISO | RGD:732023 | 6480464 | MAP2K1 protein inhibits the reaction [Curcumin inhibits the reaction [Mitomycin results in increased phosphorylation of MAPK1 protein]]; more ... | CTD | PMID:21810436 |
| D-mannitol | multiple interactions | EXP | | 6480464 | Mannitol inhibits the reaction [Vitamin A results in increased phosphorylation of MAP2K1 protein] | CTD | PMID:16510265 |
| dexamethasone | multiple interactions | ISO | RGD:732023 | 6480464 | Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [EGF protein results in increased phosphorylation of MAP2K1 protein]] | CTD | PMID:10807665 |
| dexamethasone | increases expression | ISO | RGD:1550208 | 6480464 | Dexamethasone results in increased expression of MAP2K1 mRNA | CTD | PMID:21041162 |
| diarsenic trioxide | increases expression | ISO | RGD:732023 | 6480464 | arsenic trioxide results in increased expression of MAP2K1 mRNA | CTD | PMID:22521957 |
| diarsenic trioxide | decreases phosphorylation | ISO | RGD:732023 | 6480464 | arsenic trioxide results in decreased phosphorylation of MAP2K1 protein | CTD | PMID:20592496 |
| diazoxide | multiple interactions | EXP | | 6480464 | MAP2K1 protein affects the reaction [Isoproterenol results in increased phosphorylation of and results in increased activity of MAPK1 protein]; more ... | CTD | PMID:10888249 |
| diazoxide | multiple interactions | ISO | RGD:1550208 | 6480464 | MAP2K1 protein promotes the reaction [Isoproterenol results in decreased expression of COL2A1 protein]; more ... | CTD | PMID:21177286 |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of MAP2K1 mRNA | CTD | PMID:21266533 |
| dichlorine | multiple interactions | EXP | | 6480464 | [Ozone co-treated with Chlorine] results in decreased expression of MAP2K1 mRNA | CTD | PMID:18636392 |
| dichlorine | increases expression | EXP | | 6480464 | Chlorine results in increased expression of MAP2K1 mRNA | CTD | PMID:18636392 |
| dieldrin | multiple interactions | ISO | RGD:732023 | 6480464 | Dieldrin results in increased phosphorylation of and results in increased activity of MAP2K1 protein | CTD | PMID:15888667 |
| diethylstilbestrol | increases expression | ISO | RGD:732023 | 6480464 | Diethylstilbestrol results in increased expression of MAP2K1 mRNA | CTD | PMID:15766595 |
| diethylstilbestrol | increases expression | ISO | RGD:1550208 | 6480464 | Diethylstilbestrol results in increased expression of MAP2K1 mRNA | CTD | PMID:16636312 |
| dioxygen | increases response to substance | EXP | | 6480464 | MAP2K1 protein results in increased susceptibility to Oxygen | CTD | PMID:10780954 |
| disodium selenite | decreases expression | ISO | RGD:732023 | 6480464 | Sodium Selenite results in decreased expression of MAP2K1 mRNA | CTD | PMID:16705456 |
| doxorubicin | increases phosphorylation | ISO | RGD:732023 | 6480464 | Doxorubicin results in increased phosphorylation of MAP2K1 protein | CTD | PMID:17974986 |
| doxorubicin | multiple interactions | ISO | RGD:732023 | 6480464 | [PD 98059 results in decreased activity of MAP2K1 protein] affects the reaction [SOD2 protein results in decreased susceptibility to Doxorubicin]; more ... | CTD | PMID:18594523 |
| doxorubicin | increases phosphorylation | ISO | RGD:1550208 | 6480464 | Doxorubicin results in increased phosphorylation of MAP2K1 protein | CTD | PMID:17974986 |
| emodin | multiple interactions | EXP | | 6480464 | Emodin inhibits the reaction [PDGFB protein results in increased phosphorylation of MAP2K1 protein] | CTD | PMID:15288473 |
| endosulfan | multiple interactions | ISO | RGD:732023 | 6480464 | Endosulfan results in increased phosphorylation of and results in increased activity of MAP2K1 protein | CTD | PMID:15888667 |
| ethacrynic acid | increases expression | ISO | RGD:732023 | 6480464 | Ethacrynic Acid results in increased expression of MAP2K1 protein | CTD | PMID:14556662 |
| ethanol | affects expression | EXP | | 6480464 | Ethanol affects the expression of MAP2K1 mRNA | CTD | PMID:11772933 |
| ethanol | multiple interactions | EXP | | 6480464 | N-methyl-N-(6-methoxy-1-phenyl-1,2,3,4-tetrahydronaphthalen-2-ylmethyl)aminomethylcarboxylic acid inhibits the reaction [Ethanol results in decreased expression of MAP2K1 mRNA] | CTD | PMID:20655511 |
| ethanol | decreases expression | EXP | | 6480464 | Ethanol results in decreased expression of MAP2K1 mRNA | CTD | PMID:20655511 |
| fipronil | decreases activity | ISO | RGD:1550208 | 6480464 | fipronil results in decreased activity of MAP2K1 protein | CTD | PMID:21167920 |
| gallic acid | multiple interactions | ISO | RGD:732023 | 6480464 | Gallic Acid inhibits the reaction [TNF protein results in increased phosphorylation of MAP2K1 protein] | CTD | PMID:21420233 |
| gamma-hexachlorocyclohexane | multiple interactions | ISO | RGD:732023 | 6480464 | Lindane results in increased phosphorylation of and results in increased activity of MAP2K1 protein | CTD | PMID:15888667 |
| geldanamycin | multiple interactions | ISO | RGD:1550208 | 6480464 | geldanamycin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MAP2K1 protein] | CTD | PMID:8816498 |
| genistein | decreases phosphorylation | EXP | | 6480464 | Genistein results in decreased phosphorylation of MAP2K1 protein | CTD | PMID:15781664 |
| genistein | increases phosphorylation | ISO | RGD:732023 | 6480464 | Genistein results in increased phosphorylation of MAP2K1 protein | CTD | PMID:19038232 |
| haloperidol | decreases expression | EXP | | 6480464 | Haloperidol results in decreased expression of MAP2K1 mRNA | CTD | PMID:15860345 |
| heparin | multiple interactions | EXP | | 6480464 | Heparin inhibits the reaction [FGF1 protein results in increased phosphorylation of MAP2K1 protein]; more ... | CTD | PMID:14966081 |
| heptachlor | multiple interactions | ISO | RGD:732023 | 6480464 | Heptachlor results in increased phosphorylation of and results in increased activity of MAP2K1 protein | CTD | PMID:15888667 |
| heptachlor | decreases expression | ISO | RGD:732023 | 6480464 | Heptachlor results in decreased expression of MAP2K1 protein | CTD | PMID:9704902 |
| hyaluronic acid | increases phosphorylation | ISO | RGD:732023 | 6480464 | Hyaluronic Acid analog results in increased phosphorylation of MAP2K1 protein | CTD | PMID:12402308 |
| hydrogen peroxide | increases activity | ISO | RGD:732023 | 6480464 | Hydrogen Peroxide results in increased activity of MAP2K1 protein | CTD | PMID:15242773 |
| hydrogen peroxide | increases activity | ISO | RGD:732023 | 6480464 | Hydrogen Peroxide results in increased activity of MAP2K1 protein | CTD | PMID:15242773 PMID:19038233 |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of MAP2K1 mRNA | CTD | PMID:18299717 |
| ionomycin | multiple interactions | EXP | | 6480464 | Ionomycin inhibits the reaction [MAP2K1 protein results in increased expression of CALCA mRNA] | CTD | PMID:12574409 |
| isoprenaline | multiple interactions | EXP | | 6480464 | MAP2K1 protein affects the reaction [Isoproterenol results in increased phosphorylation of and results in increased activity of MAPK1 protein]; more ... | CTD | PMID:10888249 |
| isoprenaline | multiple interactions | ISO | RGD:1550208 | 6480464 | MAP2K1 protein promotes the reaction [Isoproterenol results in decreased expression of COL2A1 protein]; more ... | CTD | PMID:21177286 |
| ketamine | multiple interactions | ISO | RGD:1550208 | 6480464 | Ketamine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of MAP2K1 protein] | CTD | PMID:19540866 |
| lead diacetate | multiple interactions | ISO | RGD:732023 | 6480464 | bisindolylmaleimide I inhibits the reaction [lead acetate results in increased phosphorylation of and results in increased activity of MAP2K1 protein]; more ... | CTD | PMID:11861786 |
| lead(0) | increases phosphorylation | ISO | RGD:732023 | 6480464 | Lead results in increased phosphorylation of MAP2K1 protein | CTD | PMID:19133285 |
| letrozole | increases expression | ISO | RGD:1550208 | 6480464 | letrozole results in increased expression of MAP2K1 protein | CTD | PMID:15967659 |
| lithium atom | multiple interactions | ISO | RGD:1550208 | 6480464 | [Lithium results in increased phosphorylation of and results in increased activity of MAP3K8 protein] which results in increased phosphorylation of MAP2K1 protein | CTD | PMID:19159680 |
| LY294002 | multiple interactions | ISO | RGD:732023 | 6480464 | MAP2K1 protein inhibits the reaction [[2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with fludarabine] results in increased cleavage of CASP3 protein] | CTD | PMID:15850772 |
| LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [MAP2K1 protein results in increased phosphorylation of EIF4EBP1 protein]; more ... | CTD | PMID:12411397 |
| lycopene | increases expression | ISO | RGD:732023 | 6480464 | lycopene results in increased expression of MAP2K1 mRNA | CTD | PMID:16886892 |
| mercaptopurine | decreases phosphorylation | ISO | RGD:732023 | 6480464 | 6-Mercaptopurine results in decreased phosphorylation of MAP2K1 protein | CTD | PMID:12697733 |
| methamphetamine | increases expression | EXP | | 6480464 | Methamphetamine results in increased expression of MAP2K1 protein | CTD | PMID:19826936 |
| methamphetamine | decreases expression | ISO | RGD:1550208 | 6480464 | Methamphetamine results in decreased expression of MAP2K1 protein | CTD | PMID:16192988 |
| methylmercury chloride | affects expression | ISO | RGD:1550208 | 6480464 | methylmercuric chloride affects the expression of MAP2K1 mRNA | CTD | PMID:21613230 |
| mifepristone | multiple interactions | ISO | RGD:732023 | 6480464 | Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [EGF protein results in increased phosphorylation of MAP2K1 protein]] | CTD | PMID:10807665 |
| mitomycin C | multiple interactions | ISO | RGD:732023 | 6480464 | MAP2K1 protein inhibits the reaction [Curcumin inhibits the reaction [Mitomycin results in increased expression of RAD51 protein]]; more ... | CTD | PMID:21810436 |
| myricetin | multiple interactions | ISO | RGD:1550208 | 6480464 | myricetin binds to and results in decreased activity of MAP2K1 protein; more ... | CTD | PMID:17693661 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:732023 | 6480464 | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K1 protein] | CTD | PMID:18703135 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K1 protein] | CTD | PMID:18703135 |
| N-methyl-N-nitrosurea | multiple interactions | EXP | | 6480464 | Methylnitrosourea results in increased phosphorylation of and results in increased activity of MAP2K1 protein | CTD | PMID:12693035 |
| nickel dichloride | affects expression | EXP | | 6480464 | nickel chloride affects the expression of MAP2K1 mRNA | CTD | PMID:22110744 |
| ozone | multiple interactions | EXP | | 6480464 | [Ozone co-treated with Chlorine] results in decreased expression of MAP2K1 mRNA | CTD | PMID:18636392 |
| paclitaxel | multiple interactions | ISO | RGD:732023 | 6480464 | [Tretinoin co-treated with Paclitaxel] results in decreased expression of MAP2K1 protein | CTD | PMID:18098270 |
| paclitaxel | multiple interactions | ISO | RGD:732023 | 6480464 | [PD 98059 results in decreased activity of MAP2K1 protein] affects the reaction [SOD2 protein results in decreased susceptibility to Paclitaxel]; more ... | CTD | PMID:18594523 |
| perfluorooctane-1-sulfonic acid | increases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in increased expression of MAP2K1 mRNA | CTD | PMID:20136073 |
| perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of MAP2K1 mRNA | CTD | PMID:19162173 |
| phenylephrine | multiple interactions | EXP | | 6480464 | MAP2K1 protein affects the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein]; more ... | CTD | PMID:10888249 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:732023 | 6480464 | PIN1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAP2K1 protein] | CTD | PMID:20479004 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1550208 | 6480464 | 3,5,3',4',5'-pentahydroxy-stilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MAP2K1 protein] | CTD | PMID:18767048 |
| phorbol 13-acetate 12-myristate | increases activity | ISO | RGD:1550208 | 6480464 | Tetradecanoylphorbol Acetate results in increased activity of MAP2K1 protein | CTD | PMID:17693661 more ... |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:732023 | 6480464 | Tetradecanoylphorbol Acetate inhibits the reaction [lead acetate results in increased phosphorylation of and results in increased activity of MAP2K1 protein] | CTD | PMID:11861786 |
| phorbol 13-acetate 12-myristate | increases activity | ISO | RGD:1550208 | 6480464 | Tetradecanoylphorbol Acetate results in increased activity of MAP2K1 protein | CTD | PMID:8816498 PMID:17693661 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:732023 | 6480464 | MAP2K1 protein affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of PPARG protein]; more ... | CTD | PMID:16945329 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1550208 | 6480464 | myricetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MAP2K1 protein] | CTD | PMID:17693661 |
| phorbol 13-acetate 12-myristate | increases activity | ISO | RGD:1550208 | 6480464 | Tetradecanoylphorbol Acetate results in increased activity of MAP2K1 protein | CTD | PMID:17693661 PMID:8816498 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1550208 | 6480464 | geldanamycin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MAP2K1 protein] | CTD | PMID:8816498 |
| phorbol 13-acetate 12-myristate | increases phosphorylation | ISO | RGD:732023 | 6480464 | Tetradecanoylphorbol Acetate results in increased phosphorylation of MAP2K1 protein | CTD | PMID:20479004 |
| propiconazole | increases expression | ISO | RGD:1550208 | 6480464 | propiconazole results in increased expression of MAP2K1 mRNA | CTD | PMID:21278054 |
| propofol | multiple interactions | ISO | RGD:1550208 | 6480464 | Propofol inhibits the reaction [lipoteichoic acid results in increased phosphorylation of MAP2K1 protein] | CTD | PMID:19573522 |
| purine-6-thiol | decreases phosphorylation | ISO | RGD:732023 | 6480464 | 6-Mercaptopurine results in decreased phosphorylation of MAP2K1 protein | CTD | PMID:12697733 |
| quercetin | multiple interactions | ISO | RGD:1550208 | 6480464 | Quercetin binds to and results in decreased activity of MAP2K1 protein | CTD | PMID:18245498 |
| quinoline | decreases activity | ISO | RGD:732023 | 6480464 | quinoline results in decreased activity of MAP2K1 protein | CTD | PMID:18393446 |
| resveratrol | decreases phosphorylation | ISO | RGD:732023 | 6480464 | resveratrol results in decreased phosphorylation of MAP2K1 protein | CTD | PMID:16761963 |
| resveratrol | increases expression | ISO | RGD:732023 | 6480464 | resveratrol results in increased expression of MAP2K1 mRNA | CTD | PMID:12154049 |
| resveratrol | increases activity | ISO | RGD:732023 | 6480464 | resveratrol results in increased activity of MAP2K1 protein | CTD | PMID:15615701 |
| resveratrol | decreases activity | ISO | RGD:732023 | 6480464 | resveratrol results in decreased activity of MAP2K1 protein | CTD | PMID:15698585 |
| rosiglitazone | multiple interactions | EXP | | 6480464 | rosiglitazone inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAP2K1 protein] | CTD | PMID:21247645 |
| sirolimus | multiple interactions | ISO | RGD:732023 | 6480464 | [7-hydroxystaurosporine co-treated with Sirolimus] results in decreased expression of MAP2K1 protein; more ... | CTD | PMID:15767555 |
| sirolimus | multiple interactions | EXP | | 6480464 | Sirolimus inhibits the reaction [MAP2K1 protein results in increased activity of RPS6KB1 protein]; more ... | CTD | PMID:12411397 |
| sodium fluoride | increases phosphorylation | EXP | | 6480464 | Sodium Fluoride results in increased phosphorylation of MAP2K1 protein | CTD | PMID:19900517 |
| sumatriptan | multiple interactions | EXP | | 6480464 | Sumatriptan inhibits the reaction [MAP2K1 protein results in increased expression of CALCA mRNA]; more ... | CTD | PMID:12574409 |
| tamoxifen | multiple interactions | ISO | RGD:732023 | 6480464 | Tamoxifen promotes the reaction [PIN1 protein binds to MAP2K1 protein] | CTD | PMID:20479004 |
| tamoxifen | increases expression | EXP | | 6480464 | Tamoxifen results in increased expression of MAP2K1 protein modified form | CTD | PMID:17901229 |
| tamoxifen | decreases expression | EXP | | 6480464 | Tamoxifen results in decreased expression of MAP2K1 protein modified form | CTD | PMID:17901229 |
| testosterone | increases activity | ISO | RGD:732023 | 6480464 | [Testosterone results in increased activity of RAF1 protein] which results in increased activity of MAP2K1 protein | CTD | PMID:20372086 |
| testosterone | multiple interactions | EXP | | 6480464 | [FSHB protein co-treated with 1-Methyl-3-isobutylxanthine] inhibits the reaction [Testosterone promotes the reaction [RAF1 results in increased phosphorylation of MAP2K1 protein]]; more ... | CTD | PMID:21177760 |
| tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of MAP2K1 mRNA | CTD | PMID:17805973 |
| toluene | affects expression | EXP | | 6480464 | Toluene affects the expression of MAP2K1 mRNA | CTD | PMID:21827849 |
| trans-resveratrol | decreases phosphorylation | ISO | RGD:732023 | 6480464 | resveratrol results in decreased phosphorylation of MAP2K1 protein | CTD | PMID:16761963 |
| trans-resveratrol | increases expression | ISO | RGD:732023 | 6480464 | resveratrol results in increased expression of MAP2K1 mRNA | CTD | PMID:12154049 |
| trans-resveratrol | increases activity | ISO | RGD:732023 | 6480464 | resveratrol results in increased activity of MAP2K1 protein | CTD | PMID:15615701 |
| trans-resveratrol | decreases activity | ISO | RGD:732023 | 6480464 | resveratrol results in decreased activity of MAP2K1 protein | CTD | PMID:15698585 |
| trichostatin A | multiple interactions | ISO | RGD:732023 | 6480464 | MAP2K1 protein mutant form results in decreased activity of [D 21266 co-treated with trichostatin A]; more ... | CTD | PMID:15781658 |
| trimethyltin | increases expression | ISO | RGD:1550208 | 6480464 | trimethyltin results in increased expression of MAP2K1 mRNA | CTD | PMID:20833246 |
| troglitazone | multiple interactions | ISO | RGD:732023 | 6480464 | MAP2K1 protein promotes the reaction [troglitazone results in increased expression of ATF3 mRNA] | CTD | PMID:16079301 |
| vanadyl sulfate | multiple interactions | ISO | RGD:732023 | 6480464 | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [vanadyl sulfate results in increased phosphorylation of MAP2K1 protein]; more ... | CTD | PMID:10564177 |
| vanadyl sulfate | increases phosphorylation | ISO | RGD:732023 | 6480464 | vanadyl sulfate results in increased phosphorylation of MAP2K1 protein | CTD | PMID:11943669 |
| vanadyl sulfate | multiple interactions | ISO | RGD:732023 | 6480464 | MRAS mutant form inhibits the reaction [vanadyl sulfate results in increased phosphorylation of MAP2K1 protein] | CTD | PMID:11943669 |
| zinc sulfate | multiple interactions | ISO | RGD:732023 | 6480464 | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [Zinc Sulfate results in increased phosphorylation of MAP2K1 protein]; more ... | CTD | PMID:10564177 |
| zinc sulfate | multiple interactions | ISO | RGD:732023 | 6480464 | MRAS mutant form inhibits the reaction [Zinc Sulfate results in increased phosphorylation of MAP2K1 protein] | CTD | PMID:11943669 |
| zinc sulfate | increases phosphorylation | ISO | RGD:732023 | 6480464 | Zinc Sulfate results in increased phosphorylation of MAP2K1 protein | CTD | PMID:11943669 |